Could set my watch to the schedule for BTX1503, precision:commence in Q2 2017."
"The receipt of these approvals allows Botanix to transport synthetic cannabidiol drug active from its
contract manufacturing facility in Pennsylvania, to its clinical packaging site in Melbourne. The import
of this first shipment of synthetic cannabidiol into Australia represents a key milestone as the
Company prepares to commence the first human clinical trials of BTX 1503, the Company’s lead
program for the treatment of acne. The safety and pharmacokinetic studies are scheduled to
Good stuff!
Ann: Export and Import Approvals for Clinical Studies Received, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.010(6.25%) |
Mkt cap ! $333.3M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 18.0¢ | 16.0¢ | $3.403M | 19.98M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11400 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 1048293 | 11 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| BOT (ASX) Chart |